Page last updated: 2024-09-04

carbapenems and Adverse Drug Event

carbapenems has been researched along with Adverse Drug Event in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's3 (50.00)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Ge, W; Hu, H; Li, C; Wang, L; Xia, J1
Hagiya, H; Hamaguchi, S; Kokado, R; Morii, D; Okuno, H; Tomono, K; Ueda, A; Yamamoto, N; Yoshida, H1
Ang, B; Lew, EL; Lew, KY; Ling, LM; Lye, D; Ng, TM; Tan, M; Tan, SH; Teng, CB1
Hussar, DA1
File, TM; Redman, R1
Bailey, WJ; Chibout, SD; Clouse, HK; Cordier, A; Dieterle, F; Erdos, Z; Forest, T; Gerhold, DL; Glaab, WE; Grenet, O; Holder, D; Jin, H; Legay, F; Mahl, A; Maurer, G; Muniappa, N; Ozer, JS; Perentes, E; Reynolds, S; Roth, DR; Sina, JF; Sistare, FD; Skopek, TR; Staedtler, F; Thudium, DT; Topper, MJ; Troth, S; Verdes, P; Vlasakova, K; Vonderscher, J; Wahl, D; Yu, Y1

Other Studies

6 other study(ies) available for carbapenems and Adverse Drug Event

ArticleYear
Safety profile of carbapenems: Data mining of the FDA adverse events reporting system.
    International journal of clinical pharmacology and therapeutics, 2021, Volume: 59, Issue:9

    Topics: Adverse Drug Reaction Reporting Systems; Bayes Theorem; Carbapenems; Data Mining; Drug-Related Side Effects and Adverse Reactions; Humans; Retrospective Studies; United States; United States Food and Drug Administration

2021
Association of Adverse Drug Events with Broad-spectrum Antibiotic Use in Hospitalized Patients: A Single-center Study.
    Internal medicine (Tokyo, Japan), 2019, Sep-15, Volume: 58, Issue:18

    Topics: Adult; Anti-Bacterial Agents; Carbapenems; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Incidence; Male; Meropenem; Middle Aged; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Vancomycin; Young Adult

2019
Safety and clinical outcomes of carbapenem de-escalation as part of an antimicrobial stewardship programme in an ESBL-endemic setting.
    The Journal of antimicrobial chemotherapy, 2015, Volume: 70, Issue:4

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Clostridioides difficile; Clostridium Infections; Diarrhea; Drug Therapy; Drug Utilization; Drug-Related Side Effects and Adverse Reactions; Endemic Diseases; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Patient Readmission; Retrospective Studies; Survival Analysis; Treatment Outcome

2015
New drugs08, part 2.
    Nursing, 2008, Volume: 38, Issue:7

    Topics: Acromegaly; Adult; Anti-Bacterial Agents; Anti-HIV Agents; Antineoplastic Agents; Biopterins; Carbapenems; Child; Child, Preschool; Cyclohexanes; Doripenem; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Epothilones; Humans; Infant; Maraviroc; Peptides, Cyclic; Pharmaceutical Preparations; Phenylketonurias; Pyrimidines; Pyrrolidinones; Raltegravir Potassium; Sirolimus; Somatostatin; Triazoles

2008
Safety of intravenous infusion of doripenem.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009, Aug-15, Volume: 49 Suppl 1

    Topics: Anti-Bacterial Agents; Area Under Curve; Carbapenems; Cross Infection; Doripenem; Drug Stability; Drug-Related Side Effects and Adverse Reactions; Humans; Hypersensitivity; Infusions, Intravenous; Injections, Intravenous; Microbial Sensitivity Tests; Pneumonia, Ventilator-Associated; Quality Control

2009
A panel of urinary biomarkers to monitor reversibility of renal injury and a serum marker with improved potential to assess renal function.
    Nature biotechnology, 2010, Volume: 28, Issue:5

    Topics: Animals; Biomarkers, Pharmacological; Blood Urea Nitrogen; Carbapenems; Creatinine; Cystatin C; Drug-Related Side Effects and Adverse Reactions; Female; Gentamicins; Kidney; Kidney Diseases; Kidney Function Tests; Male; Rats; Rats, Sprague-Dawley; Rats, Wistar; ROC Curve

2010